Monitoring of Suspected Adverse Drug Reactions in Oncology Unit ...
Monitoring of Suspected Adverse Drug Reactions in Oncology Unit ...
Monitoring of Suspected Adverse Drug Reactions in Oncology Unit ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
International Journal <strong>of</strong> Research <strong>in</strong> Pharmaceutical and Biomedical Sciences ISSN: 2229-3701<br />
Table 2<br />
Disease pr<strong>of</strong>ile (type / site <strong>of</strong> malignancy) <strong>of</strong> the 163 patients receiv<strong>in</strong>g anticancer chemotherapy and<br />
compla<strong>in</strong><strong>in</strong>g <strong>of</strong> at least one adverse event.<br />
Type / site <strong>of</strong> malignancy Count Percentage<br />
1. Carc<strong>in</strong>oma breast 32 19.63<br />
2. Carc<strong>in</strong>oma lung 29 17.79<br />
3. Carc<strong>in</strong>oma ovary 19 11.66<br />
4. Carc<strong>in</strong>oma cervix 14 8.59<br />
5. Carc<strong>in</strong>oma rectum 11 6.75<br />
6. Carc<strong>in</strong>oma nose / nasopharynx / paranasal s<strong>in</strong>uses 6 3.68<br />
7. Carc<strong>in</strong>oma colon 5 3.07<br />
8. Carc<strong>in</strong>oma larynx 5 3.07<br />
9. Carc<strong>in</strong>oma tongue / oral cavity 5 3.07<br />
10. S<strong>of</strong>t tissue sarcoma 4 2.45<br />
11. Carc<strong>in</strong>oma gall bladder 3 1.84<br />
12. Carc<strong>in</strong>oma stomach 3 1.84<br />
13. Osteosarcoma 3 1.84<br />
14. Rhabdomyosarcoma 3 1.84<br />
15. Carc<strong>in</strong>oma esophagus 2 1.23<br />
16. Carc<strong>in</strong>oma penis 2 1.23<br />
17. Testicular tumor 2 1.23<br />
18. Carc<strong>in</strong>oma tonsil 2 1.23<br />
19. Carc<strong>in</strong>oma vulva 2 1.23<br />
20. Hodgk<strong>in</strong>'s lymphoma 2 1.23<br />
21. Carc<strong>in</strong>oma bladder 1 0.61<br />
22. Carc<strong>in</strong>oma maxilla 1 0.61<br />
23. Carc<strong>in</strong>oma neck 1 0.61<br />
24. Carc<strong>in</strong>oma prostate 1 0.61<br />
25. Gestational trophoblastic disease 1 0.61<br />
26. Mediast<strong>in</strong>al sem<strong>in</strong>oma 1 0.61<br />
27. Non-Hodgk<strong>in</strong>'s lymphoma 1 0.61<br />
28. Periampullary carc<strong>in</strong>oma pancreas 1 0.61<br />
29. Squamous cell carc<strong>in</strong>oma 1 0.61<br />
Vol. 1 (2) Oct – Dec 2010 www.ijrpbsonl<strong>in</strong>e.com 22
Change language